পদ্ধতির তুলনা করুন

	TED-QoL / GO-QoL: থাইরয়েড আই ডিজিজ কোয়ালিটি অফ লাইফ প্রশ্নাবলী	থাইপ্রো: থাইরয়েড-সম্পর্কিত রোগীর রিপোর্টকৃত ফলাফলের স্কেল
ক্ষেত্র	অন্তঃক্ষরা বিজ্ঞান	অন্তঃক্ষরা বিজ্ঞান
পরিবার	Process / pipeline	Process / pipeline
উদ্ভবের বছর	2001	2009
প্রবর্তক	Caroline Terwee, Markus Gerding, Frank Dekker	Torquil Watt, Jens Bjørner, Marianne Groenvold
ধরন	Patient self-report questionnaire	Patient self-report questionnaire
মৌলিক উৎস	Terwee, C. B., Gerding, M. N., Dekker, F. W., et al. (2001). Development of a disease-specific questionnaire for patients with Graves' ophthalmopathy: The GO-QoL. Br J Ophthalmol, 82(7), 773-779.	Watt, T., Bjorner, J. B., Groenvold, M., et al. (2009). Establishing construct validity for the thyroid-related patient reported outcomes (ThyPRO): An initial examination. J Clin Endocrinol Metab, 94(9), 3572-3580.
অপর নাম	GO-QoL, Graves Ophthalmopathy Quality of Life	ThyPRO-85, ThyPRO-39
সম্পর্কিত	3	3
সারসংক্ষেপ	The TED-QoL (also known as GO-QoL, Graves' Ophthalmopathy Quality of Life questionnaire) is a 16-item disease-specific instrument assessing quality of life impacts in patients with thyroid eye disease (TED), the ophthalmologic manifestation of Graves' disease. Developed by Terwee, Gerding, and colleagues in 2001, it captures both functional vision limitations and psychological distress related to the characteristic eye changes (exophthalmos, lid retraction, diplopia, appearance concerns). It is the gold-standard outcome measure for TED quality of life assessment.	ThyPRO is a comprehensive patient-reported outcome measure assessing the quality of life impact of thyroid disease and its treatment across 13 dimensions. Developed by Watt and colleagues in 2009, it is the most extensively validated thyroid-specific instrument, covering both physical and psychological domains relevant to patients with hyperthyroidism, hypothyroidism, and thyroid cancer.